Our Senior Scientific Advisors serve as an internal expert group. They also interact with other world-leading experts in various scientific discussions.
Professor Lars Lannfelt, BioArctic founder and Chairman of the Research Committee of the Board of Directors. Medical doctor with specialties in psychiatry and geriatrics, Professor of Geriatrics at Uppsala University and member of the Royal Swedish Academy of Sciences. Discoverer of the Swedish and Arctic mutations and their role in Alzheimer’s disease.
Per-Ola Freskgård, PhD, BioArctic Distinguished Scientist, with experience in innovation, new technologies and drug development in Neurovascular Biology from the Roche Innovation Center in Basel, at AstraZeneca and Novo Nordisk. Leading expert on mechanisms that increase the passage of biologic drugs across the blood-brain barrier.
Christer Möller, PhD, BioArctic Chief Scientific Officer with significant experience from academic and company driven research to develop protein-based drugs from discovery to clinical trials.